Effectiveness of Therapy Via Telemedicine Following Cochlear Implants
NCT ID: NCT02497690
Last Updated: 2021-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
77 participants
INTERVENTIONAL
2013-09-30
2019-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology
NCT03157492
Effectiveness Speech and Cognitive Therapy Implant Pre-cohlear Implantation
NCT04907929
Telemonitoring in Cochlear Implant Patient Care
NCT05566353
Individually-guided Hearing Aid Fitting
NCT03345654
Telephone vs. Voice Over IP Speech Comprehension in Hearing Aided Subjects.
NCT03005912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
In-person ART
In-person approach to provide ART.
In-person ART
Half of subjects will undergo six months of ART administered in person. Therapy will be provided in the usual manner.
Telehealth ART
Telemedicine technology approach (e.g. interactive video) to provide ART.
Telemedicine
Half of subjects will undergo six months of ART administered via telehealth. Therapy will be provided in the usual manner, except a computer will be used to facilitate the interaction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemedicine
Half of subjects will undergo six months of ART administered via telehealth. Therapy will be provided in the usual manner, except a computer will be used to facilitate the interaction.
In-person ART
Half of subjects will undergo six months of ART administered in person. Therapy will be provided in the usual manner.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* focus on recruiting families who are members of minority groups.
* therapy must be provided in English.
Exclusion Criteria
* blindness,
* severe motor impairment,
* autism,
* significant genetic/chromosomal syndrome.
6 Months
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
University of Colorado, Boulder
OTHER
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Grigsby, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-1103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.